Clinical Trial Update: AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating AQ4N in combination with radiotherapy and temozolomide for newly diagnosed glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• AQ4N (banoxantrone)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Novacea | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: UNKNOWN